Matches in Wikidata for { <http://www.wikidata.org/entity/Q87872253> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q87872253 description "article scientifique publié en janvier 2000" @default.
- Q87872253 description "artikull shkencor i botuar më 01 janar 2000" @default.
- Q87872253 description "artículu científicu espublizáu en xineru de 2000" @default.
- Q87872253 description "im Jahr 2000 veröffentlichter wissenschaftlicher Artikel" @default.
- Q87872253 description "scientific article published on 01 January 2000" @default.
- Q87872253 description "wetenschappelijk artikel" @default.
- Q87872253 description "wüsseschaftlicher Artikel, wo im Johr 2000 veröffentlicht worden isch" @default.
- Q87872253 description "наукова стаття, опублікована в січні 2000" @default.
- Q87872253 name "Candesartan Cilexetil, a Novel Angiotensin II Antagonist, Provides Dose-dependent Antihypertensive Effect with Maintained Tolerability" @default.
- Q87872253 name "Candesartan Cilexetil, a Novel Angiotensin II Antagonist, Provides Dose-dependent Antihypertensive Effect with Maintained Tolerability" @default.
- Q87872253 type Item @default.
- Q87872253 label "Candesartan Cilexetil, a Novel Angiotensin II Antagonist, Provides Dose-dependent Antihypertensive Effect with Maintained Tolerability" @default.
- Q87872253 label "Candesartan Cilexetil, a Novel Angiotensin II Antagonist, Provides Dose-dependent Antihypertensive Effect with Maintained Tolerability" @default.
- Q87872253 prefLabel "Candesartan Cilexetil, a Novel Angiotensin II Antagonist, Provides Dose-dependent Antihypertensive Effect with Maintained Tolerability" @default.
- Q87872253 prefLabel "Candesartan Cilexetil, a Novel Angiotensin II Antagonist, Provides Dose-dependent Antihypertensive Effect with Maintained Tolerability" @default.
- Q87872253 P1433 Q87872253-E72CFC36-25C4-4E5C-9907-69F6D68F436A @default.
- Q87872253 P1476 Q87872253-BC4F7535-9442-4C46-84A7-401E840F27A9 @default.
- Q87872253 P2093 Q87872253-01B2C321-9C22-4244-83B0-B7E2E645887E @default.
- Q87872253 P2093 Q87872253-44748909-738B-41DC-ACBD-DAF1D0907C39 @default.
- Q87872253 P2093 Q87872253-8D7C8E33-0184-4285-BDDC-EAA33EDD4FF1 @default.
- Q87872253 P2093 Q87872253-F52272A8-A215-470F-9935-EBC9E30192D6 @default.
- Q87872253 P304 Q87872253-0AE881E3-344C-4587-BEB0-E5F2E94FC3F3 @default.
- Q87872253 P31 Q87872253-96A6E6E4-F921-46EB-9D77-06E8DE1B6000 @default.
- Q87872253 P356 Q87872253-4E199E1B-8718-4EBD-A01E-58FB00918A6C @default.
- Q87872253 P433 Q87872253-26190F3F-5608-43C1-A517-E761042D2C57 @default.
- Q87872253 P478 Q87872253-500B4D96-6A48-4345-9B67-0B513E727312 @default.
- Q87872253 P577 Q87872253-5485B042-6796-4D8C-8074-174A6902EFEC @default.
- Q87872253 P698 Q87872253-522226FE-DE13-4877-A2A9-CF107CE1FDEC @default.
- Q87872253 P356 080370500439272 @default.
- Q87872253 P698 28425799 @default.
- Q87872253 P1433 Q15754419 @default.
- Q87872253 P1476 "Candesartan Cilexetil, a Novel Angiotensin II Antagonist, Provides Dose-dependent Antihypertensive Effect with Maintained Tolerability" @default.
- Q87872253 P2093 "B Olofsson" @default.
- Q87872253 P2093 "D Elmfeldt" @default.
- Q87872253 P2093 "M George" @default.
- Q87872253 P2093 "R Hübner" @default.
- Q87872253 P304 "54" @default.
- Q87872253 P31 Q13442814 @default.
- Q87872253 P356 "10.1080/080370500439272" @default.
- Q87872253 P433 "sup1" @default.
- Q87872253 P478 "9" @default.
- Q87872253 P577 "2000-01-01T00:00:00Z" @default.
- Q87872253 P698 "28425799" @default.